MYC and lymphoma: However, expression of the ligand genes was below detectable levels in Runx2/MYC or CD2-MYC/p53 null lymphoma cells suggesting that activation of Ccr7/9 provides a growth advantage by a paracrine mechanism that is dependent on thymic stroma.